Detalles de la búsqueda
1.
Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries.
Eur J Pediatr
; 170(2): 213-22, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20842379
2.
Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children.
Pediatr Infect Dis J
; 24(3): 219-24, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15750457
3.
Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.
Influenza Other Respir Viruses
; 9(2): 68-77, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25652873
4.
Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
J Infect
; 49(3): 242-7, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15337342
5.
Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study.
Pediatr Infect Dis J
; 29(6): e35-46, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20375709
6.
Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.
Clin Vaccine Immunol
; 14(1): 65-73, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17065257
Resultados
1 -
6
de 6
1
Próxima >
>>